Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 6, 2004, Pages 673-679

  Corbett, Elizabeth L ^a   Charalambous, Salome ^b   Moloi, Vicky M ^b   Fielding, Katherine ^b   Grant, Alison D ^b   Dye, Christopher ^b   De Cock, Kevin M ^b   Hayes, Richard J ^b   Williams, Brian C ^b   Churchyard, Gavin J ^b  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^b NONE

Author keywords

Africa; Epidemiology; Human immunodeficiency virus; Prevalence; Tuberculosis

Indexed keywords

GOLD;

ADULT; AFRICA; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MINER; MYCOBACTERIUM KANSASII; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OCCUPATIONAL DISEASE; OPPORTUNISTIC INFECTION; PREVALENCE; PRIORITY JOURNAL; SILICOSIS; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; GOLD; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MINING; PREVALENCE; RETROSPECTIVE STUDIES; SOUTH AFRICA; TIME FACTORS; TUBERCULOSIS;

EID: 4444364044     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200405-590OC     Document Type: Article

References (39)

1. Anderson RM, May RM. A framework for discussing the population biology of infectious diseases: infectious diseases of humans, 1st ed. Oxford: Oxford University Press; 1991. p. 13-26.
2. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement: global burden of tuberculosis: estimated incidence, prevalence, and mortality by country: WHO Global Surveillance and Monitoring Project. JAMA 1999;282:677-686.
3. World Health Organization. Global tuberculosis control: surveillance, planning, financing. Geneva, Switzerland: WHO Report; 2003. WHO/TB/2003.316.
4. Tupasi TE, Radhakrishna S, Rivera AB, Pascual ML, Quelapio MI, Co VM, Villa MLA, Beltran G, Legaspi JD, Mangubat NV, et al. The 1997 nationwide tuberculosis prevalence survey in the Philippines. Int J Tuberc Lung Dis 1999;3:471-477.
5. Tuberculosis Research Centre CCI. Trends in the prevalence and incidence of tuberculosis in South India. Int J Tuberc Lung Dis 2001;5:142-157.
6. The Ministry of Health of the People's Republic of China. Report on nationwide random survey for the epidemiology of tuberculosis in 2000. Beijing: Ministry of Health of the People's Republic of China; 2002.
7. Shafer RW, Edlin BR. Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade. Clin Infect Dis 1996;22:683-704.
8. Daley CL, Small PM, Schecter GF, Schoolnik GK, McAdam RA, Jacobs WR Jr, Hopewell PC. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: an analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992;326:231-235.
9. Pablos-Mendez A, Sterling TR, Frieden TR. The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA 1996;276:1223-1228.
10. Frieden TR, Sherman LF, Maw KL, Fujiwara PI, Crawford JT, Nivin B, Sharp V, Hewlett D Jr, Brudney K, Alland D, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA 1996;276:1229-1235.
11. Churchyard GJ, Kleinschmidt I, Corbett EL, Mulder D, De Cock KM. Mycobacterial disease in South African gold miners in the era of HIV infection. Int J Tuberc Lung Dis 1999;3:791-798.
12. Charalambous S, Moloi V, Grant AD, Seabi O, Mangenene N, Rankhakile MK, Churchyard GJ, Corbett EL. Impact of HIV on prevalent (active) TB disease in South African gold miners: implications for duration of infectivity, case-finding and TB transmission [abstract no. MoOrC1099]. Barcelona, Spain: XIV International AIDS Conference; 2002.
13. Corbett EL, Charalambous S, Moloi V, Fielding K, Grant AD, Dye C, De Cock KM, Hayes RJ, Williams BG, Churchyard GJ. HIV and the duration of infectivity before diagnosis of TB disease: implications for TB transmission and control in high HIV prevalence areas [abstract]. Int J Tuberc Lung Dis 2003;7:S137.
14. Corbett EL, Churchyard GJ, Clayton TC, Williams BG, Mulder D, Hayes RJ, De Cock KM. HIV infection and silicosis: the impact of two potent risk factors on mycobacterial disease incidence in South African miners. AIDS 2000;14:2759-2768.
15. Sterne JA, Turner AC, Connell JA, Parry JV, Fine PE, Ponnighaus JM, Nyasulu S, Mkandwire PK. Human immunodeficiency virus: GACPAT and GACELISA as diagnostic tests for antibodies in urine. Trans R Soc Trop Med Hyg 1993;87:181-183.
16. Corbett EL, Churchyard GJ, Charalambous S, Samb B, Moloi V, Clayton TC, Grant AD, Murray J, Hayes RJ, De Cock KM. Morbidity and mortality in South African gold miners: impact of untreated HIV infection. Clin Infect Dis 2002;34:1251-1258.
17. National Tuberculosis Institute B. Tuberculosis in a rural population of South India: a five-year epidemiological study. Bull World Health Organ 1974;51:473-488.
18. Lucas SB, Hounnou A, Peacock C, Beaumel A, Djomand G, N'Gbichi JM, Yeboue K, Honde M, Diomande M, Giordano C, et al. The mortality and pathology of HIV infection in a west African city. AIDS 1993;7:1569-1579.
19. Nelson AM, Perriens JH, Kapita B, Okonda L, Lusamuno N, Kalengayi MR, Angritt P, Quinn TC, Mullick FG. A clinical and pathological comparison of the WHO and CDC case definitions for AIDS in Kinshasa, Zaire: is passive surveillance valid? AIDS 1993;7:1241-1245.
20. Rana FS, Hawken MP, Mwachari C, Bhatt SM, Abdullah F, Ng'ang'a LW, Power C, Githui WA, Porter JD, Lucas SB. Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya. J Acquir Immune Defic Syndr 2000;24:23-29.
21. Ansari NA, Kombe AH, Kenyon TA, Hone NM, Tappero JW, Nyirenda ST, Binkin NJ, Lucas SB. Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998. Int J Tuberc Lung Dis 2002;6:55-63.
22. Dye C, Watt CJ, Bleed D. Low access to a highly effective therapy: a challenge for international tuberculosis control. Bull World Health Organ 2002;80:437-444.
23. Corbett EL, Watt CJ, Walker N, Maher D, Lazzari S, Williams BG, Raviglione MC, Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163:1009-1021.
24. Styblo K. Overview and epidemiologic assessment of the current global tuberculosis situation with an emphasis on control in developing countries. Rev Infect Dis 1989;11:S339-S346.
25. Tanzania Tuberculin Survey Collaboration. Tuberculosis control in the era of the HIV epidemic: risk of tuberculosis infection in Tanzania, 1983-1998. Int J Tuberc Lung Dis 2001;5:103-112.
26. Richards SB, St Louis ME, Nieburg P, Coulibaly IM, Coulibaly D, Abouya L, Gayle HD, De Cock KM. Impact of the HIV epidemic on trends in tuberculosis in Abidjan, Cote d'Ivoire. Tuber Lung Dis 1995;76:11-16.
27. Siriarayapon P, Yanai H, Glynn JR, Yanpaisarn S, Uthaivoravit W. The evolving epidemiology of HIV infection and tuberculosis in northern Thailand. J Acquir Immune Defic Syndr 2002;31:80-89.
28. Corbett EL, Charalambous S, Fielding K, Clayton TC, Hayes RJ, De Cock KM, Churchyard GJ. Stable tuberculosis incidence rates among HIV-negative South African gold miners during a decade of epidemic HIV-associated TB. J Infect Dis 2003;188:1156-1163.
29. Glynn JR, Crampin AC, Ngwira BM, Mwaungulu FD, Mwafulirwa DT, Floyd S, Ponnighaus JM, Warndorff DK, Fine PE. Trends in tuberculosis and the influence of HIV infection in northern Malawi, 1988-2001. AIDS 2004;18:1459-1463.
30. Odhiambo JA, Borgdorff MW, Kiambih FM, Kibuga DK, Kwamanga DO, Ng'ang'a LW, Agwanda R, Kalisvaart NA, Misljenovic O, Nagelkerke NJ, et al. Tuberculosis and the HIV epidemic: increasing annual risk of infection in Kenya, 1986-1996. Am J Public Health 1999;89:1078-1082.
31. Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, Shearer S. HIV and pulmonary tuberculosis: the impact goes beyond those infected with HIV. AIDS 2004;18:657-662.
32. Aisu T, Raviglione MC, van Praag E, Eriki P, Narain JP, Barugahare L, Tembo G, McFarland D, Engwau FA. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre. AIDS 1995;9:267-273.
33. Burgess AL, Fitzgerald DW, Severe P, Joseph P, Noel E, Rastogi N, Johnson WD Jr, Pape JW. Integration of tuberculosis screening at an HIV voluntary counselling and testing centre in Haiti. AIDS 2001;15:1875-1879.
34. Desormeaux J, Johnson MP, Coberly JS, Losikoff P, Johnson E, Huebner R, Geiter L, Davis H, Chaisson RE, Boulos R, et al. Widespread HIV counseling and testing linked to a community-based tuberculosis control program in a high risk population. Bull Pan Am Health Organ 1996;120:463-471.
35. Godfrey-Faussett P, Maher D, Mukadi YD, Nunn P, Perrin J, Raviglione M. How human immunodeficiency virus voluntary testing can contribute to tuberculosis control. Bull World Health Organ 2002;80:939-945.
36. Churchyard GJ, Corbett EL, Kleinschmidt I, Murray J, Smit J, De Cock KM. Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners. Int J Tuberc Lung Dis 2000;4:705-712.
37. Murray J, Kielkowski D, Reid P. Occupational disease trends in black South African gold miners: an autopsy-based study. Am J Respir Crit Care Med 1996;153:706-710.
38. Madico G, Gilman RH, Checkley W, Cabrera L, Kohlstadt I, Kacena K, Diaz JF, Black R. Community infection ratio as an indicator for tuberculosis control. Lancet 1995;345:416-419.
39. Classen CN, Warren R, Richardson M, Hauman JH, Gie RP, Ellis JH, van Helden PD, Beyers N. Impact of social interactions in the community on the transmission of tuberculosis in a high incidence area. Thorax 1999;54:136-140.